To investigate the relevance of H19 in soft tissue sarcoma as a potential therapeutic target, we established a gene knock‐down approach by using Gapmers directed against H19 in two independent soft tissue sarcoma cell lines (synovial sarcoma SW982 and liposarcoma SW872). The gene discussed is H19; the disease is soft tissue sarcoma.